Preserving fertility in the hypogonadal patient: An update

Asian Journal of Andrology

Volumn 17, Issue 2, 2015, Pages 197-200

  Ramasamy, Ranjith ^a   Armstrong, Joseph M ^a   Lipshultz, Larry I ^a  

^a Baylor Medical School   (United States)

Author keywords

human chorionic gonadotropin; selective estrogen receptor modulators; spermatogenesis; testosterone supplementation therapy

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; LUTEINIZING HORMONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TESTOSTERONE;

ADULT; ANDROGEN THERAPY; ATHLETE; CASE REPORT; DEPRESSION; ERECTILE DYSFUNCTION; FATIGUE; FERTILITY PRESERVATION; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPOGONADISM; HYPOPHYSIS GONAD SYSTEM; LIBIDO DISORDER; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PREVALENCE; REVIEW; SPERMATOGENESIS; SUPPLEMENTATION; TESTOSTERONE BLOOD LEVEL; ALGORITHM; AZOOSPERMIA; COMPLICATION; DEFICIENCY; DISEASE MANAGEMENT; DRUG EFFECTS; EUNUCHISM; HORMONE SUBSTITUTION; INFERTILITY, MALE; PHYSIOLOGY; PROCEDURES;

ALGORITHMS; AZOOSPERMIA; CHORIONIC GONADOTROPIN; DISEASE MANAGEMENT; EUNUCHISM; FERTILITY PRESERVATION; HORMONE REPLACEMENT THERAPY; HUMANS; INFERTILITY, MALE; MALE; SPERMATOGENESIS; TESTOSTERONE;

EID: 84924711073     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.4103/1008-682X.142772     Document Type: Review

References (20)

1. Baillargeon J, Urban RJ, Ottenbacher KJ, Pierson KS, Goodwin JS. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med 2013; 173: 1465-6.
2. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006; 60: 762-9.
3. Kovac JR, Addai J, Smith RP, Coward RM, Lamb DJ, et al. The effects of advanced paternal age on fertility. Asian J Androl 2013; 15: 723-8.
4. Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008; 371: 1872-82.
5. Buckley WE, Yesalis CE 3rd, Friedl KE, Anderson WA, Streit AL, et al. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 1988; 260: 3441-5.
6. Layton JB, Li D, Meier CR, Sharpless JL, Stürmer T, et al. Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. J Clin Endocrinol Metab 2014; 99: 835-42.
7. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001; 86: 724-31.
8. McCabe SE, Brower KJ, West BT, Nelson TF, Wechsler H. Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys. Drug Alcohol Depend 2007; 90: 243-51.
9. Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet 1990; 336: 955-9.
10. Gu Y, Liang X, Wu W, Liu M, Song S, et al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab 2009; 94: 1910-5.
11. Samplaski MK, Loai Y, Wong K, Lo KC, Grober ED, et al. Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters. Fertil Steril 2014; 101: 64-9.
12. Ko EY, Siddiqi K, Brannigan RE, Sabanegh ES Jr. Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J Urol 2012; 187: 973-8.
13. Coviello AD, Matsumoto AM, Bremner WJ, Herbst KL, Amory JK, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab 2005; 90: 2595-602.
14. Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol 2013; 189: 647-50.
15. Katz DJ, Nabulsi O, Tal R, Mulhall JP. Outcomes of clomiphene citrate treatment in young hypogonadal men. BJU Int 2012; 110: 573-8.
16. Moskovic DJ, Katz DJ, Akhavan A, Park K, Mulhall JP. Clomiphene citrate is safe and effective for long-term management of hypogonadism. BJU Int 2012; 110: 1524-8.
17. Ramasamy R, Scovell JM, Kovac JR, Lipshultz LI. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. J Urol 2014; 192: 875-9.
18. Kaminetsky J, Werner M, Fontenot G, Wiehle RD. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. J Sex Med 2013; 10: 1628-35.
19. Wiehle R, Cunningham GR, Pitteloud N, Wike J, Hsu K, et al. Testosterone restoration by enclomiphene citrate in men with secondary hypogonadism: pharmacodynamics and pharmacokinetics. BJU Int 2013.
20. Wiehle RD, Fontenot GK, Wike J, Hsu K, Nydell J, et al. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Fertil Steril 2014; 102: 720-7.